Related Experiment Video
Updated: Mar 10, 2026

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology
Published on: December 1, 2023
Biocompatibility of fluids for multiphase drops-in-drops microfluidics
Aishah Prastowo1, Alexander Feuerborn2, Peter R Cook2
1Osney Thermo-Fluids Laboratory, Department of Engineering Science, University of Oxford, Osney Mead, Oxford, OX2 0ES, UK.
This study identifies a biocompatible fluid and surfactant combination for microfluidic cell-based drug screening. The new method ensures stable gene expression in mammalian cells, improving drug discovery accuracy.
Area of Science:
- Biomedical Engineering
- Cell Biology
- Drug Discovery
Background:
- Microfluidic systems offer precise control for cell-based assays.
- Traditional microfluidic fluids can induce variability in cell gene expression.
- Mammalian cell drug screening requires biocompatible microfluidic environments.
Purpose of the Study:
- To evaluate fluid and surfactant biocompatibility in microfluidic drops-in-drops systems.
- To identify a microfluidic medium supporting stable gene expression for drug screening.
- To optimize fluidic combinations for medium to long-term cell-based drug assays.
Main Methods:
- Utilized a drops-in-drops microfluidic system with three immiscible fluids.
- Tested various fluid and surfactant combinations for cell compatibility.
- Assessed gene expression levels in Jurkat cells after drug exposure.
- Compared microfluidic screening results with conventional methods.
Main Results:
- A common fluid/surfactant combination caused significant gene expression variability.
- Identified HFE-7500 and 5-cSt silicone oil + 0.25% Abil EM180 as a suitable combination.
- This combination supported the drops-in-drops approach effectively.
- Achieved normal gene expression levels, comparable to conventional screening.
Conclusions:
- The HFE-7500 and silicone oil/Abil EM180 combination is biocompatible for microfluidic drug screening.
- This fluidic system minimizes gene expression variability in cell-based assays.
- Enables reliable medium to long-term drug screening in microfluidic platforms.
More Related Videos
07:57Taking Advantage of Reduced Droplet-surface Interaction to Optimize Transport of Bioanalytes in Digital Microfluidics
Published on: November 10, 2014
08:02Fabricating High-viscosity Droplets using Microfluidic Capillary Device with Phase-inversion Co-flow Structure
Published on: April 17, 2018